Yadira Hurley, M.D., from the department of dermatology is recruiting participants for a multi-center trial aimed at treating moderate to severe psoriasis.
Eligible persons will receive a new investigative oral medication.
Patients may be eligible if they have moderate to severe plaque psoriasis with >10% BSA affected. If a patient is currently receiving psoriasis treatment, he/she may still qualify for the study if there is >10% BSA affected after a washout period.
The study is 52 weeks with visits approximately every 4 weeks. Patients are compensated for their time and travel.
Participant may receive, at no cost, the following supplies and/or procedures: